M 515 (Mirtazapine 15 mg)

Pill imprint M 515 has been identified as Mirtazapine 15 mg.

Mirtazapine is used in the treatment of major depressive disorder; insomnia; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 515

Mirtazapine 15 mg M 515  Front
Mirtazapine 15 mg M 515  Back
Mirtazapine 15 mg M 515
Mirtazapine
Imprint:
M 515
Strength:
15 mg
Color:
Beige
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3515
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0086 UDL Laboratories Inc
54569-5895 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)